AZTR

Conviction 0HealthcareScan · Thu, Jun 25, 2026

AZTR$0.1652-21.33%

ResistanceSupportVol 14

Vol MA14 48.31M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Azitra, Inc.Pharmaceutical Preparationswww.azitrainc.com ↗

Price0.1652

Change-21.33%

Gap-12.24%

Rel volume0.32×

Avg volume33.97M

Avg $ vol6.89M

SMA 200.2093

SMA 500.2158

SMA 2000.3417

Price vs 50-23.44%

Price vs 200-51.65%

MA stackbearish

50/200 cross—

Supertrenddown · 0.2433

RSI (14)40

MACD hist-0.00

MACD crossbear · 0d

Stoch %K / %D0 / 16

ADX (14)20

+DI / −DI26 / 19

RSI divergence—

MACD divergence—

ATR %+21.28%

ADR %14.58%

52w high1.07

52w low0.1350

From 52w high-84.56%

Above 52w low+22.37%

New 52w highNo

SqueezeOn · 8d

Bollinger width34.59%

%B-0.11

Donchian pos0.18%

Donchian high0.3300

Donchian low0.1649

AVWAP (52w high)0.3618

vs AVWAP high-54.34%

AVWAP (52w low)0.2546

vs AVWAP low-35.11%

OBV trendUp

Chaikin MF (20)-0.60

Today vs 20d0.32×

Avg vol (14d)48.31M

Avg vol (20d)33.97M

Avg $ vol (20d)6.89M

Market cap2.67M

RS 3m (vs SPY)-35.70%

RS 6m (vs SPY)-36.33%

RS line new highNo

Trend template0/8

Technical rank7.1

1 week-18.62%

1 month-21.33%

3 months-34.65%

6 months-45.59%

1 year-33.87%

YTD-40.72%

P/E-0.24

P/B0.26

P/S—

P/FCF-0.24

EPS-2.25

Div yield—

ROE-104.53%

ROA-90.34%

Debt/Eq—

Current6.94

EV/EBITDA0.68

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-22.17%

Price target1.00

Target upside505.33%

Analyst ratingBuy

Institutional3.34%

Ent. value-7.38M

Revenue0

Net income-3.93M

Gross profit—

Free cash flow-11.25M

IndustryPharmaceutical Preparations

ExchangeNYSE

Shares out16.19M

Employees13

ListedFri, Jun 16, 2023

Free float15.32M

Float %96.4%

Short interest61.64K

Days to cover0.1d

Short volume50.3%

Squeeze score8 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.25

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank7.1 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.2942

Support0.1726

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AZTR

All disclosures →

No recent disclosed trades by Congress in AZTR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AZTR · 4 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Salva Francisco D. President and CEO · Common Stock · 2026-06-16	Convert	4.06M	—	2026-06-16	2026-06-18
Salva Francisco D. President and CEO · Series A Convertible Non-Redeemable Preferred Stock · 2026-06-16	Convert	500	—	2026-06-16	2026-06-18
Whitfill Travis Chief Operating Officer · Stock Options (Right To Buy) · 2026-04-20	Grant	64.3K	$0	2026-04-20	2026-04-22
Salva Francisco D. President and CEO · Stock Options (Right To Buy) · 2026-04-20	Grant	220.88K	$0	2026-04-20	2026-04-22
Staskey Norm Chief Financial Officer · Stock Options (Right To Buy) · 2026-04-20	Grant	35.52K	$0	2026-04-20	2026-04-22

SEC filings

EDGAR filings in AZTR · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.